Biotech has been one of the worst-performing industry groups this cycle. Investors have got used to it as these stocks have been dead money for much of the past decade.
Dividend Aristocrats are easily some of the most desirable investments on Wall Street. These are the names that have increased dividends for at least 25 years, providing steadily increasing...
We debuted a new scan recently which goes by the name- All Star Momentum.
All Star Momentum is a brand new scan that guides us towards the very best stocks in the market. This time around, we have incorporated our stock universe of Nifty 500...
Key Takeaway: Renewed selling pressure brings an air of disappointment rather than fear. Lackluster price action, an absence of a meaningful breadth thrust, and an overall risk-off...
Yes, it's tricky both tactically and mentally to get long in the stock market right now. One look at the broader indexes would give any rookie market technician pause.
That said, there are still pockets of strength that are working and growing...
